DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 12776 - 12800 of 62743 in total
Disease ID Disease Name Gene Symbol Gene ID Gene Name ▲ UniProt ID
C0011860 Diabetes Mellitus, Non-Insulin-Dependent MGAT4A 11320 alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A Q9UM21
C1306459 Primary malignant neoplasm MGAT4B 11282 alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B Q9UQ53
C1269683 Major Depressive Disorder MGAT4B 11282 alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B Q9UQ53
C0006826 Malignant Neoplasms MGAT4B 11282 alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B Q9UQ53
C0235974 Pancreatic carcinoma A4GNT 51146 alpha-1,4-N-acetylglucosaminyltransferase Q9UNA3
C0346647 Malignant neoplasm of pancreas A4GNT 51146 alpha-1,4-N-acetylglucosaminyltransferase Q9UNA3
C0006826 Malignant Neoplasms A4GNT 51146 alpha-1,4-N-acetylglucosaminyltransferase Q9UNA3
C0030297 Pancreatic Neoplasm A4GNT 51146 alpha-1,4-N-acetylglucosaminyltransferase Q9UNA3
C0017152 Gastritis A4GNT 51146 alpha-1,4-N-acetylglucosaminyltransferase Q9UNA3
C0030920 Peptic Ulcer A4GNT 51146 alpha-1,4-N-acetylglucosaminyltransferase Q9UNA3
C0278701 Gastric Adenocarcinoma A4GNT 51146 alpha-1,4-N-acetylglucosaminyltransferase Q9UNA3
C1306459 Primary malignant neoplasm A4GNT 51146 alpha-1,4-N-acetylglucosaminyltransferase Q9UNA3
C0699791 Stomach Carcinoma A4GNT 51146 alpha-1,4-N-acetylglucosaminyltransferase Q9UNA3
C0024623 Malignant neoplasm of stomach A4GNT 51146 alpha-1,4-N-acetylglucosaminyltransferase Q9UNA3
C0001418 Adenocarcinoma A4GNT 51146 alpha-1,4-N-acetylglucosaminyltransferase Q9UNA3
C2931008 Congenital disorder of glycosylation type 2A MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0025517 Metabolic Diseases MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0036572 Seizures MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0028754 Obesity MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0282577 Congenital Disorders of Glycosylation MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0018784 Sensorineural Hearing Loss (disorder) MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0027651 Neoplasms MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0016202 Flatfoot MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0085207 Gestational Diabetes MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469
C0011847 Diabetes MGAT2 4247 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Q10469

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024